Cadence Healthcare Ventures — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Alleviant Medical develops an investigational minimally invasive medical device using interatrial shunt therapy to treat heart failure patients, currently in FDA-approved clinical trials (ALLAY-HF and ALLAY-HFrEF).
BiotechHealthtechMedical DevicesAustin, US
Adam Berman(Executive Officer, Director)Jacob Kriegel(Executive Officer, Director)Avni Patel(Executive Officer, Director)Christopher Alex Arevalos(Executive Officer, Director)Albertien Greijdanus(Executive Officer, Director)
BoardGeoff Pardo(Director)
Board seatChristopher Kaster· per SEC Form D · $91.4M raise · filed Jan 2025
Co-investorsBroadview VenturesRiverVest Venture PartnersTMC Venture FundGilde HealthcareGilmartin Capital LLCS3 Ventures+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.